Inozyme Pharma, Inc. RESTRICTED STOCK UNIT AGREEMENT Granted under 2020 Stock Incentive PlanRestricted Stock Unit Agreement • March 12th, 2024 • Inozyme Pharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 12th, 2024 Company Industry JurisdictionThis grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. INOZYME PHARMA, INC. CONFIDENTIAL...Corporate Sponsored Research Agreement • March 12th, 2024 • Inozyme Pharma, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledMarch 12th, 2024 Company Industry JurisdictionThis RESEARCH AGREEMENT (this “Agreement”) is entered into as of January 6, 2017 (the “Effective Date”), by and between Yale University, a non-profit corporation organized and existing under and by virtue of a special charter granted by the General Assembly of the Colony and State of Connecticut (the “University”), and Inozyme Pharma, LLC, a Delaware limited liability company, having its principal offices at 240 Bluff View Drive, Guilford, Connecticut 06347 (the “Sponsor”).